Genencell - Crunchbase Company Profile & Funding

Q: Where is Genencell's headquarters?

Genencell is located in Giheung, Kyonggi-do, South Korea.

Q: Who invested in Genencell?

Genencell is funded by Sejong Medical.

Q: When was the last funding round for Genencell?

Genencell closed its last funding round on obfuscated from a Corporate Round round.

Q: How much funding has Genencell raised to date?

Genencell has raised obfuscated.

Overview

Genencell

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Genencell

CB Rank

148203

Genencell is a healthcare company that researches and develops products based on functional cosmetics and medical devices.

Founded

obfuscation

Private

Corporate Round

Giheung, Kyonggi-do, South Korea

www.genencell.co.kr

Biotechnology

Health Care

Medical

Product Research

Funding Rounds

Corporate Round

OBF

obfuscation

Details

Legal Name

Genencell Co. Ltd.

Also Known As

제넨셀

Operating Status

Active

Company Type

For Profit

Phone Number

+82 031 212 1957

Contact Email

genencell@genencell.co.kr

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

GNL-MD-RFD001

A diagnostic kit that uses a newly developed kidney disease marker to detect kidney damage early with a small urine sample.

ES16001

A candidate drug derived from the leaves of Elaeocarpus sylvestris var. ellipticus, aimed at treating herpes simplex virus type 1 and shingles.

Research & Development

Genencell is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Corporate Round - Genencell	1	obfuscated obfuscation	Sejong Medical	Corporate Round
obfuscated obfuscation	Corporate Round - Genencell	1	obfuscated obfuscation	Sejong Medical	Corporate Round
obfuscated obfuscation	Corporate Round - Genencell	1	obfuscated obfuscation	Sejong Medical	Corporate Round
obfuscated obfuscation	Corporate Round - Genencell	1	obfuscated obfuscation	Sejong Medical	Corporate Round
obfuscated obfuscation	Corporate Round - Genencell	1	obfuscated obfuscation	Sejong Medical	Corporate Round

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Corporate Round - Genencell	1	obfuscated obfuscation	Sejong Medical	Corporate Round
obfuscated obfuscation	Corporate Round - Genencell	1	obfuscated obfuscation	Sejong Medical	Corporate Round
obfuscated obfuscation	Corporate Round - Genencell	1	obfuscated obfuscation	Sejong Medical	Corporate Round
obfuscated obfuscation	Corporate Round - Genencell	1	obfuscated obfuscation	Sejong Medical	Corporate Round
obfuscated obfuscation	Corporate Round - Genencell	1	obfuscated obfuscation	Sejong Medical	Corporate Round

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Sejong Medical	Yes	Corporate Round - Genencell	—
Sejong Medical	Yes	Corporate Round - Genencell	—
Sejong Medical	Yes	Corporate Round - Genencell	—
Sejong Medical	Yes	Corporate Round - Genencell	—
Sejong Medical	Yes	Corporate Round - Genencell	—